Václav Eis

1.0k total citations
21 papers, 830 citations indexed

About

Václav Eis is a scholar working on Surgery, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Václav Eis has authored 21 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Oncology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Václav Eis's work include Chemokine receptors and signaling (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Renin-Angiotensin System Studies (3 papers). Václav Eis is often cited by papers focused on Chemokine receptors and signaling (5 papers), Nitric Oxide and Endothelin Effects (3 papers) and Renin-Angiotensin System Studies (3 papers). Václav Eis collaborates with scholars based in Czechia, Germany and United States. Václav Eis's co-authors include Volker Vielhauer, Hans‐Joachim Anders, Matthias Kretzler, Detlef Schlöndorff, Frank Strutz, Guillermo Pérez de Lema, Richard Horuk, Stephan Segerer, Yvonne Linde and Stefan Bauer and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Kidney International.

In The Last Decade

Václav Eis

20 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Václav Eis Czechia 14 314 211 178 144 138 21 830
Bunshiro Akikusa Japan 17 226 0.7× 137 0.6× 117 0.7× 106 0.7× 192 1.4× 52 832
Norma Uribe‐Uribe Mexico 17 215 0.7× 178 0.8× 106 0.6× 184 1.3× 102 0.7× 65 770
Huiyong Chen China 17 148 0.5× 219 1.0× 160 0.9× 211 1.5× 350 2.5× 61 1.1k
Makoto Sueishi Japan 18 293 0.9× 43 0.2× 106 0.6× 374 2.6× 223 1.6× 50 1.0k
Elba Reyes‐Maldonado Mexico 17 278 0.9× 40 0.2× 152 0.9× 211 1.5× 232 1.7× 75 976
J J Weening Netherlands 17 351 1.1× 296 1.4× 45 0.3× 113 0.8× 196 1.4× 34 1.1k
Pamela Kimball United States 18 234 0.7× 115 0.5× 169 0.9× 154 1.1× 208 1.5× 56 1.0k
Masafumi Sugiyama Japan 16 336 1.1× 71 0.3× 87 0.5× 362 2.5× 324 2.3× 47 817
Morito Endo Japan 20 574 1.8× 508 2.4× 46 0.3× 53 0.4× 252 1.8× 59 1.1k

Countries citing papers authored by Václav Eis

Since Specialization
Citations

This map shows the geographic impact of Václav Eis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Václav Eis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Václav Eis more than expected).

Fields of papers citing papers by Václav Eis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Václav Eis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Václav Eis. The network helps show where Václav Eis may publish in the future.

Co-authorship network of co-authors of Václav Eis

This figure shows the co-authorship network connecting the top 25 collaborators of Václav Eis. A scholar is included among the top collaborators of Václav Eis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Václav Eis. Václav Eis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kynčl, Martin, et al.. (2025). Chiasmatic syndrome caused by Rathke's cleft cyst: A case report. Molecular and Clinical Oncology. 22(6). 1–6.
2.
Skálová, Alena, Abbas Agaimy, Tomáš Vaněček, et al.. (2020). Molecular Profiling of Clear Cell Myoepithelial Carcinoma of Salivary Glands With EWSR1 Rearrangement Identifies Frequent PLAG1 Gene Fusions But No EWSR1 Fusion Transcripts. The American Journal of Surgical Pathology. 45(1). 1–13. 51 indexed citations
3.
Eis, Václav, et al.. (2019). Panniculitis-like T-cell-lymphoma in the mesentery associated with hemophagocytic syndrome: autopsy case report. Diagnostic Pathology. 14(1). 80–80. 12 indexed citations
4.
Svatoň, Michael, Markéta Žaliová, Karel Fišer, et al.. (2019). Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors. Cancers. 11(9). 1316–1316. 17 indexed citations
5.
Eis, Václav, et al.. (2017). [Synchronous colorectal carcinoma and non-Hodgkin lymphoma - two case reports].. PubMed. 95(9). 369–372. 2 indexed citations
6.
Eis, Václav, et al.. (2017). Zwei synchrone Malignome in einem Nephrektomiepräparat. Der Pathologe. 39(1). 65–70. 1 indexed citations
8.
Hrbáček, Jan, Mi­chael Urban, Eva Hamšíková, et al.. (2011). Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer. 11(1). 53–53. 39 indexed citations
9.
Hrbáček, Jan, Václav Eis, Eva Hamšíková, et al.. (2010). [Urologic complications of HIV infection].. PubMed. 149(3). 115–9. 3 indexed citations
10.
Vernerová, Zdeňka, Herbert J. Kramer, Angela Bäcker, et al.. (2008). Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats. Vascular Pharmacology. 48(4-6). 165–173. 16 indexed citations
11.
Heráček, Jiří, Michelle M. Hill, Richard Hampl, et al.. (2007). 92 TISSUE AND SERUM LEVELS OF PRINCIPAL ANDROGENS IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER. European Urology Supplements. 6(2). 45–45. 11 indexed citations
12.
Chábová, Věra Čertíková, Herbert J. Kramer, Ivana Vaněčková, et al.. (2007). Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats. Vascular Pharmacology. 47(2-3). 145–159. 35 indexed citations
13.
Opočenský, Martin, Herbert J. Kramer, Angela Bäcker, et al.. (2006). Late-Onset Endothelin-A Receptor Blockade Reduces Podocyte Injury in Homozygous Ren-2 Rats Despite Severe Hypertension. Hypertension. 48(5). 965–971. 48 indexed citations
14.
Vaněčková, Ivana, Herbert J. Kramer, Angela Bäcker, et al.. (2006). Early-onset endothelin receptor blockade in hypertensive heterozygous Ren-2 rats. Vascular Pharmacology. 45(3). 163–170. 15 indexed citations
15.
Eis, Václav, Volker Vielhauer, & Hans‐Joachim Anders. (2005). Targeting the chemokine network in renal inflammation.. PubMed. 52(3). 164–72. 12 indexed citations
16.
Eis, Václav, Bruno Luckow, Volker Vielhauer, et al.. (2004). Chemokine Receptor CCR1 But Not CCR5 Mediates Leukocyte Recruitment and Subsequent Renal Fibrosis after Unilateral Ureteral Obstruction. Journal of the American Society of Nephrology. 15(2). 337–347. 111 indexed citations
17.
Vielhauer, Volker, Václav Eis, Matthias Kretzler, et al.. (2004). CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome. Kidney International. 66(6). 2264–2278. 127 indexed citations
18.
Vielhauer, Volker, Václav Eis, Detlef Schlöndorff, & Hans‐Joachim Anders. (2004). Identifying Chemokines as Therapeutic Targets in Renal Disease: Lessons from Antagonist Studies and Knockout Mice. Kidney & Blood Pressure Research. 27(4). 226–238. 27 indexed citations
19.
Anders, Hans‐Joachim, Václav Eis, Stephan Segerer, et al.. (2004). Late Onset of Treatment with a Chemokine Receptor CCR1 Antagonist Prevents Progression of Lupus Nephritis in MRL-Fas(lpr) Mice. Journal of the American Society of Nephrology. 15(6). 1504–1513. 91 indexed citations
20.
Anders, Hans‐Joachim, Volker Vielhauer, Václav Eis, et al.. (2004). Activation of toll‐like receptor‐9 induces progression of renal disease in MRL‐Fas(lpr) mice. The FASEB Journal. 18(3). 534–536. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026